Narrow search
Showing 1 - 10 of 165
Cover Image
Risk selection into supplemental private health insurance in China
Jiang, Yawen; Ni, Weiyi - In: Health economics review 9 (2019) 36, pp. 1-11
Background: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively...
Persistent link: https://www.econbiz.de/10012162528
Cover Image
Promoting vaccinations - an analysis of measures taken by German statutory health insurers
Damm, Kathrin; Schubert, Jana M.; Schulenburg, … - In: Health economics review 1 (2011) 16, pp. 1-6
Introduction: Prophylactic vaccinations play a significant role in health care. As a relatively cost-effective preventive measure they can help to avert transmissible diseases and thus protect not only the vaccinated individuals themselves but also those who have not been vaccinated. In order to...
Persistent link: https://www.econbiz.de/10009503925
Cover Image
Utilization of healthcare services and renewal of health insurance membership : evidence of adverse selection in Ghana
Duku, Stephen Kwasi Opoku; Asenso-Boadi, Francis; … - In: Health economics review 6 (2016) 43, pp. 1-12
Background: Utilization of healthcare in Ghana’s novel National Health Insurance Scheme (NHIS) has been increasing since inception with associated high claims bill which threatens the scheme’s financial sustainability. This paper investigates the presence of adverse selection by assessing...
Persistent link: https://www.econbiz.de/10011586649
Cover Image
The role of risk preferences : voluntary health insurance in rural Tanzania
Kagaigai, Alphoncina; Grepperud, Sverre - In: Health economics review 13 (2023) 1, pp. 1-15
Background Lower-middle-income countries (LMICs) have a common goal to achieve universal health coverage (UHC) through voluntary health insurance schemes. This is important to improve access to healthcare services and ensure fnancial protection for all by reducing out-of-pocket expenditures....
Persistent link: https://www.econbiz.de/10014500306
Cover Image
Competition between health maintenance organizations and nonintegrated health insurance companies in health insurance markets
Baranes, Edmond; Bardey, David - In: Health economics review 5 (2015) 36, pp. 1-9
This article examines a model of competition between two types of health insurer: Health Maintenance Organizations (HMOs) and nonintegrated insurers. HMOs vertically integrate health care providers and pay them at a competitive price, while nonintegrated health insurers work as indemnity plans...
Persistent link: https://www.econbiz.de/10011472211
Cover Image
Patient dumping, outlier payments, and optimal healthcare payment policy under asymmetric information
Takahara, Tsuyoshi - In: Health economics review 6 (2016) 57, pp. 1-11
We analyze a rationale for official authorization of patient dumping in the prospective payment policy framework. We show that when the insurer designs the healthcare payment policy to let hospitals dump high-cost patients, there is a trade-off between the disutility of dumped patients (changes...
Persistent link: https://www.econbiz.de/10011587193
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …
Persistent link: https://www.econbiz.de/10012291135
Cover Image
The impact of reimbursement negotiations on cost and availability of new pharmaceuticals: evidence from an online experiment
Wettstein, Dominik J.; Boes, Stefan - In: Health economics review 10 (2020) 13, pp. 1-15
Background: The necessity to measure and reward "value for money" of new pharmaceuticals has become central in health … study assesses the impact of a negotiation situation for lifeextending pharmaceuticals on societal outcomes. Of interest …
Persistent link: https://www.econbiz.de/10012291180
Cover Image
The effect of altruism on COVID-19 vaccination rates
Hierro, Luis Á.; Patiño, David; Atienza, Pedro; … - In: Health economics review 13 (2023) 1, pp. 1-12
Background: After the emergence of the frst vaccines against the COVID-19, public health authorities have promoted mass vaccination in order to achieve herd immunity and reduce the efects of the disease. Vaccination rates have difered between countries, depending on supply (availability of...
Persistent link: https://www.econbiz.de/10013492973
Cover Image
Incentivizing COVID-19 vaccination among racial/ethnic minority adults in the United States : $ 209 per dose could convince the hesitant
Chen, Kevin; Wilson-Barthes, Marta; Harris, Jeffrey E.; … - In: Health economics review 13 (2023) 1, pp. 1-11
Background More than two years into the coronavirus disease (COVID-19) pandemic, it remains unclear whether fnancial incentives can reduce vaccine hesitancy and improve uptake among key unvaccinated populations. This study estimated the willingness of racial/ethnic minority adults in the United...
Persistent link: https://www.econbiz.de/10013492975